Today CareRx Corp climbed above its 200-day moving average line and it closed above it, a long-term BULLISH signal.
It did so on more than 7 times average daily volume.
TradingView's technical analysis summary is BUY:
https://www.tradingview.com/symbols/TSX-CRRX/
This stock's average analyst rating is BUY and its price target is $7.75:
https://www.theglobeandmail.com/investing/markets/stocks/CRRX-T/research/
That is more than 69.78% higher than the current price of $4.27.
Lately, investment funds have been buying shares of this stock on a net basis:
https://www.morningstar.ca/ca/report/stocks/ownership.aspx?t=0P00005SDU&lang=en-CA
And so far this year, insiders have been buying this stock:
https://www.canadianinsider.com/node/7?menu_tickersearch=CRRX%2B%7C%2BCareRx
GLTA!
It did so on more than 7 times average daily volume.
TradingView's technical analysis summary is BUY:
https://www.tradingview.com/symbols/TSX-CRRX/
This stock's average analyst rating is BUY and its price target is $7.75:
https://www.theglobeandmail.com/investing/markets/stocks/CRRX-T/research/
That is more than 69.78% higher than the current price of $4.27.
Lately, investment funds have been buying shares of this stock on a net basis:
https://www.morningstar.ca/ca/report/stocks/ownership.aspx?t=0P00005SDU&lang=en-CA
And so far this year, insiders have been buying this stock:
https://www.canadianinsider.com/node/7?menu_tickersearch=CRRX%2B%7C%2BCareRx
GLTA!
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
